Clinical trial
The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol. Tapering Methotrexate in Patients With Rheumatoid Arthritis Beginning Therapy With Infliximab
NCT00246064 is registered in ClinicalTrials.gov with Centocor Ortho Biotech Services, L.L.C. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol. Tapering Methotrexate in Patients With Rheumatoid Arthritis Beginning Therapy With Infliximab
- Lead sponsor
- Centocor Ortho Biotech Services, L.L.C.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2001
- Completion date
- November 30, 2003
- Enrollment
- 210 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.